CN104940553A - Medicine for treating lumbar muscle strain - Google Patents
Medicine for treating lumbar muscle strain Download PDFInfo
- Publication number
- CN104940553A CN104940553A CN201510424251.7A CN201510424251A CN104940553A CN 104940553 A CN104940553 A CN 104940553A CN 201510424251 A CN201510424251 A CN 201510424251A CN 104940553 A CN104940553 A CN 104940553A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- medicine
- roots
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to medicine for treating the lumbar muscle strain. The medicine comprises, by weight, 1-10 parts of herba agrimoniae, 10-20 parts of suberect spatholobus stems, 10-20 parts of sassafras, 5-15 parts of tuber onion seeds, 1-10 parts of eucommia bark, 5-15 parts of medicinal cyathula roots, 5-15 parts of roots of axillaryflower twistedstalk, 1-10 parts of Chinese dodder seeds, 10-20 parts of arborvitae tops, 10-20 parts of flat-stemmed tetrastigma, 10-20 parts of alligator weeds, 1-10 parts of frankincense, 5-15 parts of roots of fragrant sarcococca, 10-20 parts of fructus viticis, 10-20 parts of white chinaure herbs, 10-20 parts of lysimachia candida, 1-10 parts of liquoric roots, 5-15 parts of Sichuan dolomiaea roots, 5-15 parts of jasminum lanceolarium, 10-20 parts of knotweed, 10-20 parts of pine nuts and 10-20 parts of littleleaf Indian mulberry herbs. The medicine for treating the lumbar muscle strain has a definite clinical treatment effect, can improve the living quality of a patient, and is worthy of clinical application and popularization.
Description
The divisional application of the patent of " a kind of medicament for the treatment of lumbar muscle strain " that the present invention is application number is 201510078608.0, the applying date, to be February 13, denomination of invention in 2015 be.
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of lumbar muscle strain.
Background technology
Lumbar muscle strain is also called " myofascitis of back " or " functional lumbago ", the chronic strain of the soft tissues such as main finger waist muscle, fascia, ligament causes aseptic inflammation reaction, degeneration and necrosis locally occur, and its cardinal symptom is pain, dysfunction and autonomic nervous dysfunction.It is generally acknowledged that the morbidity of chronic lumbar muscle strain is because long term accumulation damage or acute psoas damage are controlled, caused by wrong treatment protracted course of disease because losing.Along with modern's living-pattern preservation, this disease has occupied the first place of lumbar soft tissue injury, and sickness rate accounts for lumbago and skelalgia patient's 80%, is common clinical, frequently-occurring disease.Lumbar muscle strain has that sickness rate is high, the course of disease is long, not easily radical cure and the feature of easily recurrence, has had a strong impact on the work of people, study and daily life.
Current doctor trained in Western medicine there is no specific drug to this disease, mainly take Western medicine sedation-analgesia or carry out local hormone closed treating, be difficult to tackle the problem at its root, so that Relapse rate outbreak, and be often associated with untoward reaction and complication, then wound is large, sequela is many for operative therapy, and late result is not good, is not accepted by most doctor and patient.And Chinese medicine have accumulated rich experience in control lumbar muscle strain.Lumbar muscle strain belongs to the category of the traditional Chinese medical science " lumbago " " muscle and tendon injury " " arthromyodynia ", treats based on acupuncture, massage, physical therapy, internal and external medicine, has the advantages such as determined curative effect, side effect be little, more easily by extensive patients is accepted.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of lumbar muscle strain.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of lumbar muscle strain, it is made up of the material of following weight portion: Herba Agrimoniae 1-10 part, Caulis Spatholobi 10-20 part, Cinnamomum porrectum (Roxb.) Kosterm. 10-20 part, Semen Allii Tuberosi 5-15 part, Cortex Eucommiae 1-10 part, Radix Cyathulae 5-15 part, bamboo grove clouds 5-15 part, Semen Cuscutae 1-10 part, Cacumen Platycladi 10-20 part, Caulis et Radix Tetrastigmatis Planicaulis 10-20 part, red Alternanthera sessilis (L.) DC. 10-20 part, Olibanum 1-10 part, Radix Sarcococcae Ruscifoliae (Herba Sarcoclccae Ruscifoliae) 5-15 part, Fructus Viticis 10-20 part, Herba Boenninghauseniae Albiflorae 10-20 part, Herba Lysimachiae Candidae 10-20 part, Radix Glycyrrhizae 1-10 part, little Radix Aristolochiae yunnanensis 5-15 part, Radix seu Caulis Jasmini lanceolarii 5-15 part, Rhizoma Polygoni Paleachi 10-20 part, Semen pini koraiensis 10-20 part, Herba Morindae Parvifoliae 10-20 part.
Preferably, the medicament for the treatment of lumbar muscle strain of the present invention is made up of the material of following weight portion: Herba Agrimoniae 5 parts, Caulis Spatholobi 15 parts, Cinnamomum porrectum (Roxb.) Kosterm. 12 parts, Semen Allii Tuberosi 10 parts, the Cortex Eucommiae 8 parts, Radix Cyathulae 10 parts, bamboo grove clouds 12 parts, Semen Cuscutae 8 parts, Cacumen Platycladi 15 parts, Caulis et Radix Tetrastigmatis Planicaulis 12 parts, red Alternanthera sessilis (L.) DC. 15 parts, Olibanum 5 parts, Radix Sarcococcae Ruscifoliae (Herba Sarcoclccae Ruscifoliae) 10 parts, Fructus Viticis 15 parts, Herba Boenninghauseniae Albiflorae 15 parts, Herba Lysimachiae Candidae 12 parts, 9 parts, Radix Glycyrrhizae, little Radix Aristolochiae yunnanensis 10 parts, Radix seu Caulis Jasmini lanceolarii 10 parts, Rhizoma Polygoni Paleachi 15 parts, Semen pini koraiensis 15 parts, Herba Morindae Parvifoliae 15 parts.
More preferably, described medicament can be tablet, dispersible tablet, capsule, soft capsule or ointment.
The present invention also provides the purposes of compositions in the medicine of preparation treatment lumbar muscle strain, described compositions is made up of the material of following weight portion: Herba Agrimoniae 1-10 part, Caulis Spatholobi 10-20 part, Cinnamomum porrectum (Roxb.) Kosterm. 10-20 part, Semen Allii Tuberosi 5-15 part, Cortex Eucommiae 1-10 part, Radix Cyathulae 5-15 part, bamboo grove clouds 5-15 part, Semen Cuscutae 1-10 part, Cacumen Platycladi 10-20 part, Caulis et Radix Tetrastigmatis Planicaulis 10-20 part, red Alternanthera sessilis (L.) DC. 10-20 part, Olibanum 1-10 part, Radix Sarcococcae Ruscifoliae (Herba Sarcoclccae Ruscifoliae) 5-15 part, Fructus Viticis 10-20 part, Herba Boenninghauseniae Albiflorae 10-20 part, Herba Lysimachiae Candidae 10-20 part, Radix Glycyrrhizae 1-10 part, little Radix Aristolochiae yunnanensis 5-15 part, Radix seu Caulis Jasmini lanceolarii 5-15 part, Rhizoma Polygoni Paleachi 10-20 part, Semen pini koraiensis 10-20 part, Herba Morindae Parvifoliae 10-20 part.
Preferably, described compositions is made up of the material of following weight portion: Herba Agrimoniae 5 parts, Caulis Spatholobi 15 parts, Cinnamomum porrectum (Roxb.) Kosterm. 12 parts, Semen Allii Tuberosi 10 parts, the Cortex Eucommiae 8 parts, Radix Cyathulae 10 parts, bamboo grove clouds 12 parts, Semen Cuscutae 8 parts, Cacumen Platycladi 15 parts, Caulis et Radix Tetrastigmatis Planicaulis 12 parts, red Alternanthera sessilis (L.) DC. 15 parts, Olibanum 5 parts, Radix Sarcococcae Ruscifoliae (Herba Sarcoclccae Ruscifoliae) 10 parts, Fructus Viticis 15 parts, Herba Boenninghauseniae Albiflorae 15 parts, Herba Lysimachiae Candidae 12 parts, 9 parts, Radix Glycyrrhizae, little Radix Aristolochiae yunnanensis 10 parts, Radix seu Caulis Jasmini lanceolarii 10 parts, Rhizoma Polygoni Paleachi 15 parts, Semen pini koraiensis 15 parts, Herba Morindae Parvifoliae 15 parts.
More preferably, described medicine can be tablet, dispersible tablet, capsule, soft capsule or ointment.
In the present compositions, Herba Boenninghauseniae Albiflorae, little Radix Aristolochiae yunnanensis, bamboo grove clouds are monarch drug; The Cortex Eucommiae, Cinnamomum porrectum (Roxb.) Kosterm., Herba Lysimachiae Candidae, Radix seu Caulis Jasmini lanceolarii, Rhizoma Polygoni Paleachi, Radix Sarcococcae Ruscifoliae (Herba Sarcoclccae Ruscifoliae), Herba Morindae Parvifoliae are ministerial drug; Herba Agrimoniae, Caulis Spatholobi, Semen Allii Tuberosi, Semen Cuscutae, Cacumen Platycladi, Caulis et Radix Tetrastigmatis Planicaulis, red Alternanthera sessilis (L.) DC., Olibanum, Radix Cyathulae, Fructus Viticis, Semen pini koraiensis are adjuvant drug; Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, for making medicine.
Theory of Chinese medical science is thought, " impairment of blood by looking for a long time, excessive rest on bed impairing QI, prolonged sitting injuring the muscles, prolonged standing injuring bones, prolonged walking injuring tendons are meaning five kinds of impairments caused by overstrain ".Lumbar muscle strain belongs to the traditional Chinese medical science " lumbago " category, and deficiency of both the liver and kidney causes lumbar muscle strain originally, and exopathogen invasion and attack, impairment caused by overstrain blood stasis are the marks causing lumbar muscle strain.Medicament of the present invention, according to the Therapeutic Principle for the treatment of both the principal and secondary aspects of a disease, based on removing blood stasis and activating blood flow, removing obstruction in the collateral to relieve pain, is aided with liver and kidney tonifying, fills blood, bone and muscle strengthening, and the clinical efficacy for the treatment of lumbar muscle strain is definite, can improve the quality of life of patient, clinic application and promoting.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modification that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
The preparation of embodiment medicament of the present invention
For ointment, the preparation technology of medicament of the present invention is as follows:
(1) Herba Agrimoniae 50 grams, Caulis Spatholobi 150 grams, Cinnamomum porrectum (Roxb.) Kosterm. 120 grams, Semen Allii Tuberosi 100 grams, the Cortex Eucommiae 80 grams, Radix Cyathulae 100 grams, bamboo grove clouds 120 grams, Semen Cuscutae 80 grams, Cacumen Platycladi 150 grams, Caulis et Radix Tetrastigmatis Planicaulis 120 grams, red Alternanthera sessilis (L.) DC. 150 grams, Olibanum 50 grams, Radix Sarcococcae Ruscifoliae (Herba Sarcoclccae Ruscifoliae) 100 grams, Fructus Viticis 150 grams, Herba Boenninghauseniae Albiflorae 150 grams, Herba Lysimachiae Candidae 120 grams, 90 grams, Radix Glycyrrhizae, little Radix Aristolochiae yunnanensis 100 grams, Radix seu Caulis Jasmini lanceolarii 100 grams, Rhizoma Polygoni Paleachi 150 grams, Semen pini koraiensis 150 grams, Herba Morindae Parvifoliae 150 grams;
(2) Olibanum, Rhizoma Polygoni Paleachi are ground into smalls, cross 120 mesh sieves, for subsequent use;
(3) Caulis Spatholobi, the Cortex Eucommiae, Cinnamomum porrectum (Roxb.) Kosterm., bamboo grove clouds, Fructus Viticis, little Radix Aristolochiae yunnanensis, Caulis et Radix Tetrastigmatis Planicaulis are put into container, soak 2 hours in the dehydrated alcohol of 6000 milliliters, filter, make filtrate evaporate to dryness, pulverize;
(4) Herba Agrimoniae, Semen Cuscutae, Semen Allii Tuberosi, Radix Cyathulae, Cacumen Platycladi, red Alternanthera sessilis (L.) DC., Radix Sarcococcae Ruscifoliae (Herba Sarcoclccae Ruscifoliae), Herba Boenninghauseniae Albiflorae, Herba Lysimachiae Candidae, Radix Glycyrrhizae, Radix seu Caulis Jasmini lanceolarii, Semen pini koraiensis, Herba Morindae Parvifoliae are put into container, add 6000ml water, under the condition of backflow, heating 1 hour, filters, make filtrate evaporate to dryness, pulverize;
(5) ground product in combining step (2)-(4), adds 500 grams of lanolines, stirs, and is dispensed in 100 flexible pipes, obtains final product.
The curative effect of experimental example medicament of the present invention
1 data and method
1.1 physical data
This group lumbar muscle strain patient is totally 60 examples." disease of tcm Standardization of diagnosis and curative effect " that diagnostic criteria is promulgated with reference to nineteen ninety-five State Administration of Traditional Chinese Medicine is formulated, specific as follows:
1. long-term pain history is had, recurrent exerbation;
2. one or both sides lumbosacral region is ached discomfort.Heavy when time is light, touchingly not heal.Tired postemphasis, alleviates after rest;
3. one or both sides musculus sacrospinalis mild tenderness, waist lower limb is movable general without obvious obstacle.
60 routine patients are divided into treatment group 30 example and matched group 30 example.Wherein treatment group male 12 example, women 18 example; Patient age between 27-49 year, 38.5 years old mean age; The course of disease 21.4 ± 4.8 months.Matched group male 11 example, women 19 example; Patient age between 29-53 year, 39.4 years old mean age; The course of disease 22.5 ± 3.6 months.Two groups of patients, at the equal not statistically significant of the difference of sex, age, the course of disease (p > 0.05), have comparability.
1.2 observation index
Draft with reference to " new Chinese medicine guideline of clinical investigations " (2002 editions, 342-346 page), adopt the method for scoring to carry out record to affected part pain, tenderness and handicapped degree.Specifically in table 1.
Table 1 curative effect index standards of grading
1.3 Therapeutic Method
Treatment group uses in embodiment the ointment of the present invention prepared to be applied to affected part, applies 1 every day, uses 1 pipe ointment at every turn, is a course for the treatment of with 7 days, 2 courses for the treatment of of continuous coating.Matched group takes composite tablet sheet (lot number: the accurate word H20050180 of traditional Chinese medicines, Shandong Lunan pharmaceutical Co. Ltd produces), 3 times/day, 2 pieces/times, is a course for the treatment of, took for 2 courses for the treatment of continuously with 7 days.
1.4 criterion of therapeutical effect
Formulate with reference to " new Chinese medicine guideline of clinical investigations " (2002 editions, 342-346 page).According to before treatment, rear twice scoring score value calculates therapeutic index (N) and effective percentage with treatment.
Cure: lumbago transference cure, waist activity freely, N >=90%.
Effective: pain symptom disappears substantially, waist activity is normal, can participate in normal activity and work, N >=70%, < 90%.
Effective: pain disappears substantially, waist activity is slightly limited, and the ability of activity or work is improved, N >=30%, < 70%.
Invalid: not reach effective standard, N < 30%
Wherein,
Score value × 100% before therapeutic index (N)=(before treatment the rear score value of score value-treatment)/treatment
Effective percentage=(cure+effective+effectively) number of cases/total number of cases × 100%
1.5 statistical method
SPSS17.0 statistical software is adopted to carry out statistical procedures.Measurement data represents with x ± s, and carries out normality distribution and homogeneity test of variance, adopts t inspection; Enumeration data compares employing x
2inspection.Think there is statistical significance with p < 0.05.
2 results
2.1 curative effect index scorings
Score value of marking before and after two groups of patient treatments change relatively in table 2.
The comparison of table 2 liang group scoring score value change
Note: compare with before treatment, * p<0.05; Compare with matched group, * * p<0.05
As can be seen from Table 2, the no significant difference (p > 0.05) of score value before two groups of patient treatments.And after treating 14 days, the score value of two groups declines all to some extent, difference has statistical significance (p<0.05), and treatment group comparatively matched group decline more obvious, group difference has statistical significance (p<0.05).
2.2 therapeutic effect
Two groups of patient outcomes relatively in table 3.
The comparison of table 3 liang group therapeutic effect
Note: compare with matched group, * p<0.05
Table 3 shows, and the difference of two groups of patient outcomes has statistical significance (p<0.05).This shows that treatment group symptom takes a turn for the better and is better than matched group, and the clinical efficacy of medicament of the present invention is better than composite tablet sheet.
Claims (3)
1. the purposes of compositions in the medicine of preparation treatment lumbar muscle strain, it is characterized in that described compositions is made up of the material of following weight portion: Herba Agrimoniae 1-10 part, Caulis Spatholobi 10-20 part, Cinnamomum porrectum (Roxb.) Kosterm. 10-20 part, Semen Allii Tuberosi 5-15 part, Cortex Eucommiae 1-10 part, Radix Cyathulae 5-15 part, bamboo grove clouds 5-15 part, Semen Cuscutae 1-10 part, Cacumen Platycladi 10-20 part, Caulis et Radix Tetrastigmatis Planicaulis 10-20 part, red Alternanthera sessilis (L.) DC. 10-20 part, Olibanum 1-10 part, Radix Sarcococcae Ruscifoliae (Herba Sarcoclccae Ruscifoliae) 5-15 part, Fructus Viticis 10-20 part, Herba Boenninghauseniae Albiflorae 10-20 part, Herba Lysimachiae Candidae 10-20 part, Radix Glycyrrhizae 1-10 part, little Radix Aristolochiae yunnanensis 5-15 part, Radix seu Caulis Jasmini lanceolarii 5-15 part, Rhizoma Polygoni Paleachi 10-20 part, Semen pini koraiensis 10-20 part, Herba Morindae Parvifoliae 10-20 part.
2. purposes according to claim 1, wherein said compositions is made up of the material of following weight portion: Herba Agrimoniae 5 parts, Caulis Spatholobi 15 parts, Cinnamomum porrectum (Roxb.) Kosterm. 12 parts, Semen Allii Tuberosi 10 parts, the Cortex Eucommiae 8 parts, Radix Cyathulae 10 parts, bamboo grove clouds 12 parts, Semen Cuscutae 8 parts, Cacumen Platycladi 15 parts, Caulis et Radix Tetrastigmatis Planicaulis 12 parts, red Alternanthera sessilis (L.) DC. 15 parts, Olibanum 5 parts, Radix Sarcococcae Ruscifoliae (Herba Sarcoclccae Ruscifoliae) 10 parts, Fructus Viticis 15 parts, Herba Boenninghauseniae Albiflorae 15 parts, Herba Lysimachiae Candidae 12 parts, 9 parts, Radix Glycyrrhizae, little Radix Aristolochiae yunnanensis 10 parts, Radix seu Caulis Jasmini lanceolarii 10 parts, Rhizoma Polygoni Paleachi 15 parts, Semen pini koraiensis 15 parts, Herba Morindae Parvifoliae 15 parts.
3. purposes according to claim 1 and 2, wherein said medicine can be tablet, dispersible tablet, capsule, soft capsule or ointment.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510078608.0A CN104606455B (en) | 2015-02-13 | 2015-02-13 | A kind of medicament for the treatment of lumbar muscle strain |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510078608.0A Division CN104606455B (en) | 2015-02-13 | 2015-02-13 | A kind of medicament for the treatment of lumbar muscle strain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104940553A true CN104940553A (en) | 2015-09-30 |
Family
ID=53141275
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510424251.7A Pending CN104940553A (en) | 2015-02-13 | 2015-02-13 | Medicine for treating lumbar muscle strain |
| CN201510078608.0A Expired - Fee Related CN104606455B (en) | 2015-02-13 | 2015-02-13 | A kind of medicament for the treatment of lumbar muscle strain |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510078608.0A Expired - Fee Related CN104606455B (en) | 2015-02-13 | 2015-02-13 | A kind of medicament for the treatment of lumbar muscle strain |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN104940553A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108686134A (en) * | 2018-09-03 | 2018-10-23 | 王加海 | A kind of preparation method of pharmaceutical capsules that treating lumbar muscle strain |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101032569A (en) * | 2007-04-03 | 2007-09-12 | 蒋坤元 | Drink medicine good for spine |
| CN102552519A (en) * | 2011-12-31 | 2012-07-11 | 曾爱荣 | Chinese medicine composition for activating blood and stopping pain, preparation process and application |
| CN103301282A (en) * | 2013-06-21 | 2013-09-18 | 成都中医药大学 | Pharmaceutical composition for treating muscle strain as well as preparation method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000072615A (en) * | 1998-08-24 | 2000-03-07 | Masatoshi Sato | Mixture containing medical herb |
| CN103330863A (en) * | 2013-06-24 | 2013-10-02 | 徐双双 | Traditional Chinese medicinal preparation for treating low back and leg pain |
-
2015
- 2015-02-13 CN CN201510424251.7A patent/CN104940553A/en active Pending
- 2015-02-13 CN CN201510078608.0A patent/CN104606455B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101032569A (en) * | 2007-04-03 | 2007-09-12 | 蒋坤元 | Drink medicine good for spine |
| CN102552519A (en) * | 2011-12-31 | 2012-07-11 | 曾爱荣 | Chinese medicine composition for activating blood and stopping pain, preparation process and application |
| CN103301282A (en) * | 2013-06-21 | 2013-09-18 | 成都中医药大学 | Pharmaceutical composition for treating muscle strain as well as preparation method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 全坤山等: "壮腰汤治疗腰肌劳损58例", 《中国骨与关节损伤杂志》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104606455B (en) | 2015-09-16 |
| CN104606455A (en) | 2015-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488869B (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
| CN103751310B (en) | A kind of traditional Chinese medicine for external application and its preparation method treating fascitis | |
| CN102100754A (en) | Chinese medicinal composition for treating osteoproliferation | |
| CN104840599B (en) | A kind of medicine for treating ankylosing spondylitis | |
| CN112915173A (en) | Traditional Chinese medicine composition for treating orthopedic diseases, preparation method and application | |
| CN104984191A (en) | Traditional Chinese medicine composition for treating acute lumbar muscle sprain | |
| CN103656325A (en) | Incision nursing substance for treating post-operation incision sensory discomfort | |
| CN109453314A (en) | A kind of Chinese medicine composition fumigated for gynaecology's postoperative rehabilitation | |
| CN104606455B (en) | A kind of medicament for the treatment of lumbar muscle strain | |
| CN103656244A (en) | Partial nursing matter capable of improving discomfort after healing of knife cut wounds | |
| CN105853969A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spinal stenosis and preparation method thereof | |
| CN102028768B (en) | Traditional Chinese medicament for treating lumbar canal stenosis | |
| CN105288059A (en) | Traditional Chinese medicine fumigating and washing agent for treating anchylosis after wrist fracture | |
| CN104971286A (en) | Traditional Chinese medicine composition for treating shoulder, waist and leg discomfort | |
| CN115177690B (en) | Traditional Chinese medicine composition for treating osteoarthritis and preparation method thereof | |
| CN115192689B (en) | Traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain, application and traditional Chinese medicine preparation thereof | |
| CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
| CN104306734A (en) | Plaster preparation for external use for treating diabetic gangrene and preparation method thereof | |
| CN105687659A (en) | Medicine patch for treating cesarean-postoperative abdominal incision sclerosis | |
| CN105194093A (en) | Traditional Chinese medicine composition for treating bone fracture | |
| CN104435883A (en) | Traditional Chinese medicine preparation for treating calcaneodynia | |
| CN116173160A (en) | External swelling-diminishing pain-relieving formula and application thereof | |
| CN103705556A (en) | Traditional Chinese medicinal composition for treating lockjaw | |
| CN116077573A (en) | Traditional Chinese medicine for dredging channels and collaterals and preparation method thereof | |
| CN103007203A (en) | Medicinal liquor for treating osteoproliferation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150930 |
|
| WD01 | Invention patent application deemed withdrawn after publication |